- Home
- OMCL vs TNDM Comparison
OMCL vs TNDM Comparison
Compare OMCL & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- TNDM
- Stock Information
- Founded
- OMCL 1992
- TNDM 2006
- Country
- OMCL United States
- TNDM United States
- Employees
- OMCL N/A
- TNDM N/A
- Industry
- OMCL Computer Manufacturing
- TNDM Medical/Dental Instruments
- Sector
- OMCL Technology
- TNDM Health Care
- Exchange
- OMCL Nasdaq
- TNDM Nasdaq
- Market Cap
- OMCL 2.0B
- TNDM 1.9B
- IPO Year
- OMCL 2001
- TNDM 2013
- Fundamental
- Price
- OMCL $42.49
- TNDM $35.40
- Analyst Decision
- OMCL Buy
- TNDM Buy
- Analyst Count
- OMCL 6
- TNDM 16
- Target Price
- OMCL $50.00
- TNDM $52.06
- AVG Volume (30 Days)
- OMCL 489.8K
- TNDM 1.1M
- Earning Date
- OMCL 02-06-2025
- TNDM 02-26-2025
- Dividend Yield
- OMCL N/A
- TNDM N/A
- EPS Growth
- OMCL N/A
- TNDM N/A
- EPS
- OMCL N/A
- TNDM N/A
- Revenue
- OMCL $1,064,205,999.00
- TNDM $854,351,000.00
- Revenue This Year
- OMCL N/A
- TNDM $23.98
- Revenue Next Year
- OMCL $5.24
- TNDM $10.89
- P/E Ratio
- OMCL N/A
- TNDM N/A
- Revenue Growth
- OMCL N/A
- TNDM 10.75
- 52 Week Low
- OMCL $25.12
- TNDM $21.85
- 52 Week High
- OMCL $55.75
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- OMCL 44.45
- TNDM 49.36
- Support Level
- OMCL $41.87
- TNDM $34.33
- Resistance Level
- OMCL $45.38
- TNDM $37.84
- Average True Range (ATR)
- OMCL 1.17
- TNDM 1.81
- MACD
- OMCL -0.06
- TNDM -0.28
- Stochastic Oscillator
- OMCL 38.56
- TNDM 24.56
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.